Didanosine-induced hypertriglyceridemia.
作者信息
Tal A, Dall L
机构信息
University of Missouri-Kansas, City School of Medicine.
出版信息
Am J Med. 1993 Aug;95(2):247. doi: 10.1016/0002-9343(93)90271-p.
PMID:8356993
Abstract
摘要
相似文献
1
Didanosine-induced hypertriglyceridemia.去羟肌苷引起的高甘油三酯血症。
Am J Med. 1993 Aug;95(2):247. doi: 10.1016/0002-9343(93)90271-p.
2
Didanosine-induced hypertriglyceridemia.去羟肌苷引起的高甘油三酯血症。
Am J Med. 1995 Jan;98(1):103. doi: 10.1016/S0002-9343(99)80094-1.
3
Pancreatitis in AIDS patients treated with didanosine.接受去羟肌苷治疗的艾滋病患者中的胰腺炎。
Am J Gastroenterol. 1993 Mar;88(3):459-60.
4
Fatal case of 2',3'-dideoxyinosine-associated pancreatitis.与2',3'-双脱氧肌苷相关的致命性胰腺炎病例。
Lancet. 1990 Dec 15;336(8729):1515. doi: 10.1016/0140-6736(90)93228-h.
5
Analysis of potential risk factors associated with the development of pancreatitis in phase I patients with AIDS or AIDS-related complex receiving didanosine.
J Infect Dis. 1994 Jun;169(6):1250-5. doi: 10.1093/infdis/169.6.1250.
6
Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI).
Ann Intern Med. 1991 Aug 15;115(4):283-4. doi: 10.7326/0003-4819-115-4-283.
7
8
AIDS drug update: DDI and DDC.
RN. 1991 Nov;54(11):41-3.
9
NIAID updates dideoxyinosine toxicity profile, suggests ways to reduce risk of pancreatitis.美国国立过敏与传染病研究所更新了去羟肌苷的毒性概况，提出降低胰腺炎风险的方法。
Clin Pharm. 1990 Nov;9(11):832, 838.
10
ddI--a good start, but still phase I.双脱氧肌苷——一个良好的开端，但仍处于第一阶段。
N Engl J Med. 1990 May 10;322(19):1386-8. doi: 10.1056/NEJM199005103221909.
引用本文的文献
1
Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era.在高效抗逆转录病毒治疗时代，抗逆转录病毒疗法的使用及依从性对HIV感染患者高脂血症风险的影响。
Oncotarget. 2017 Nov 15;8(63):106369-106381. doi: 10.18632/oncotarget.22465. eCollection 2017 Dec 5.
Zotero 插件